Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: Thomson Reuters Stock Report
Provider: MacroRisk Analytics/EconomicInvestor
Provider: ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Myriad Genetics, Inc. gives FY 2015 guidance; EPS guidance below analysts' estimates

Tuesday, 12 Aug 2014 04:05pm EDT 

Myriad Genetics, Inc:Expects FY 2015 revenue of $800 to $820 million.Expects FY 2015 adjusted diluted earnings per share of $1.90 to $2.00.Expects FY 2015 GAAP EPS guidance of $1.75 to $1.85.FY 2015 revenue of $816 million and EPS of $2.09 - Thomson Reuters I/B/E/S. 

Related Company News

Company Quote

4 May 2015